Management and Treatment Congo hemorrhagic fever - PowerPoint PPT Presentation

1 / 32
About This Presentation
Title:

Management and Treatment Congo hemorrhagic fever

Description:

... hemoptysis haematemesis/ melena adrenal bleeding Complications of CCHF DIC in the most severe cases Hepatic dysfunction severe hepatitis and necrosis ... – PowerPoint PPT presentation

Number of Views:270
Avg rating:3.0/5.0
Slides: 33
Provided by: Dewald
Category:

less

Transcript and Presenter's Notes

Title: Management and Treatment Congo hemorrhagic fever


1
Management and Treatment Congo hemorrhagic fever
  • Dr. D. Steyn
  • Department of
  • Internal Medicine
  • UOFS

2
(No Transcript)
3
Syndromes - Zoonotic viruses
  • VHFs are zoonotic infections and only
    occasionally cause illness in man
  • fever and myalgia
  • arthritis and rash
  • encephalitis
  • haemorrhagic fever

4
Crim-Congo Haemorrhagic Fever
  • 1944 - Crimean region (Soviet Union)
  • 1956 - Congo
  • 1981 - 1st case in RSA (10 - 12 cases/y)
  • Reservoirs cattle, sheep, goats, birds
    (ostriches) and hares
  • Vector Hyalomma tick (bontpootbosluis)
  • Humans become infected by contact with ticks or
    blood (not airborne)

5
(No Transcript)
6
(No Transcript)
7
  • Larvae and nymphs feed on small mammals
  • up to hare size
  • and ground-frequenting birds
  • while adults prefer
  • large animals
  • Prof. R Swanepoel

8
Humans gain infection from tick bite
or from contact of infected fresh blood (or
other tissues) with broken skin
infected blood/tissues coming either from human
patients (nosocomial infections - needle sticks
etc) or other animals, commonly sheep and
cattle Prof. R Swanepoel
9
Airborne transmission
  • Airborne transmission involving humans is
    considered a possibility only in rare instances
    from persons with advanced stages of disease
  • (e.g., one patient with Lassa fever who had
    extensive pulmonary involvement may have
    transmitted infection by the airborne route)

10
Clinical manifestation
  • Incubation period 3-6 days !!
  • Abrupt onset (Flu-like symptoms)
  • High fever with chills (400C, /- 8 days)
  • Severe headache
  • Myalgia (back ache)
  • Arthralgia
  • Abdominal pain

11
Clinical manifestation
  • Nausea/vomiting
  • Sore Throat
  • Conjunctivitis
  • Jaundice (hepatomegaly 50)
  • Splenomegaly (2-25)
  • Photophobia
  • Flushing of the face
  • Dry tongue, with a coating of dry blood

12
(No Transcript)
13
Complications of CCHF
  • Diarrhoea, vomiting, dizziness, confusion and
    abnormal behaviour
  • Haemorrhagic manifestations
  • oozing from arterial or venous puncture sites
  • petechiae, purpura, ecchymosis
  • mucosal bleeding
  • epistaxis, hemoptysis
  • haematemesis/ melena
  • adrenal bleeding

14
(No Transcript)
15
Complications of CCHF
  • DIC in the most severe cases
  • Hepatic dysfunction
  • severe hepatitis and necrosis
  • Kidney failure
  • Respiratory failure (ARDS)
  • Mostly in the severely ill, gt 5th day

16
Complications of CCHF
  • uncontrollable haemorrhage
  • shock
  • intercurrent infection
  • multi-organ failure
  • nuchal rigidity, excitation, coma
  • Mortality /- 30 (15 to 70)

17
Laboratory results
  • leucopenia (WCC lt 1000/mm3)
  • severe thrombocytopenia
  • hepatic dysfunction
  • markedly elevated liver enzymes
  • prolonged PT/PTT
  • Proteinuria / hematuria
  • Markers of organ failure

18
Poor prognostic markers
  • WCC ? 10 x 109/l
  • Platelet count ? 20 x 109/l
  • AST ? 200 U/l
  • ALT ? 150 U/l
  • APTT ? 60 seconds
  • Fibrinogen ? 110 mg/dl
  • Any one of these during the first 5 days are
    highly predictive of a fatal outcome

19
Diagnosis
  • Physician awareness
  • contact with livestock/blood of Pt with CCHF/
    bitten by a tick/ crushed tick with bare hands
  • The longer the delay in making the diagnosis, the
    greater the cost
  • specific Ab/ virus detection
  • (biosafety level 4 lab)

20
Differential diagnosis
  • Meningococ- septicaemia
  • Malaria
  • Typhoid
  • Gram- septicaemia
  • Severe Rickettsial Diseases (Tick-bite fever)
  • Hepatitis (fulminant)
  • DIC/ anticoagulant therapy
  • Systemic herpes, VZ, CMV, EBV and haemorrhagic
    measles
  • Snake-bite

21
Criteria for Clinical dx of CCHF
  • 1.) History of exposure to infection
  • 2.) Signs and symptoms
  • 3.) Clinical pathology during first 5 days of
    illness
  • Total gt 12 Points
  • Treat as a case
    of CCHF
  • R Swanepoel, J H Mynhardt, Harvey - 1987

22
1.) History of exposure
  • Incubation period
    lt 1w / gt1w
  • Bitten or crushed tick 3
    2
  • Direct contact with blood/
  • tissues of livestock 3
    2
  • Direct contact with blood/
  • secretions from CCHF Pt 3
    2
  • Resided or visited rural
  • environment 2
    1

23
2.) Signs and Symptoms
  • Sudden onset 1
  • Fever gt 38o C 1
  • Severe headache 1
  • Myalgia 1
  • Nausea /- Vomiting 1
  • Bleeding tendency 3

24
3.) Clinical pathology (1st 5 days)
  • WCC lt 3 or gt 9 1
  • Platelets lt 150
    1
  • Platelets lt 100
    2
  • gt 50 ? WCC/ Pl within 3 days
    1
  • Abnormal PI
    1
  • Abnormal PTT 1
  • AST gt 100
    1
  • ALT gt 100 1

25
Management of a suspected case of VHF
  • Universal precautions are generally sufficient
    during the pre-hospital evaluation and transport
  • Pts are less likely to vomiting, diarrhoea or
    haemorrhage
  • respiratory symptoms (cough or rhinitis)
  • face shields or surgical masks and eye protection

26
Hospitalization
  • A negative pressure room is not required during
    the early stages of illness
  • barrier precautions
  • cough, vomiting, diarrhoea, or haemorrhage
  • additional precautions are indicated to prevent
    possible exposure to airborne particles
  • Notification
  • Observation of Contact Persons (2-3 w)

27
Transfer
  • Contact your referral hospital
  • Ideally patients should be managed at the
    hospital where they are first admitted
  • they do not tolerate the stress of transfer well,
    and evacuation increases the potential of
    secondary transmission
  • If indicated transfer before bleeding start
  • Mmeticulous infection practice
  • Sedation

28
(No Transcript)
29
Treatment
  • Treatment of CCHF is mainly supportive
  • fluid and electrolyte balance
  • intensive care / ventilation
  • Support of specific organ failure
  • Intensive supportive sometimes for prolonged
    periods
  • Management of severe bleeding
  • Multiple platelet transfusions
  • Fresh frozen plasma

30
Treatment
  • Secondary infections should be treated
    aggressively with broad-spectrum antibiotics
  • Convalescent immune serum (first 3 days)
  • Ribavirin
  • Convalescence is often slow
  • Discharge of Patient (/- after 3 weeks)
  • Observation of contact persons (2-3 weeks)

31
Notification
32
(No Transcript)
Write a Comment
User Comments (0)
About PowerShow.com